Benzinga's Top Initiations

Loading...
Loading...
Jefferies initiated coverage on
Sarepta Therapeutics IncSRPT
with a Hold rating. The target price for Sarepta Therapeutics is set to $28. Sarepta Therapeutics shares closed at $24.23 on Thursday. Analysts at BMO Capital initiated initiated coverage on
TransCanada Corporation (USA)TRP
with a Outperform rating. TransCanada shares closed at $34.24 on Thursday. Jefferies initiated coverage on
PTC Therapeutics, Inc. PTCT
with a Hold rating. The target price for PTC Therapeutics is set to $26. PTC Therapeutics shares closed at $24.99 on Thursday. Analysts at Brean Capital initiated coverage of
Xtant Medical Holdings IncXTNT
with a Buy rating. The target price for Xtant Medical Holdings is set to $10. Xtant Medical Holdings shares closed at $3.30 on Thursday. Analysts at Jefferies initiated coverage on
Ignyta Inc RXDX
with a Buy rating. The target price for Ignyta is set to $18. Ignyta shares closed at $10.02 on Thursday. Jefferies initiated coverage on
Alnylam Pharmaceuticals, Inc.ALNY
with a Buy rating. The target price for Alnylam Pharmaceuticals is set to $107. Alnylam Pharmaceuticals shares closed at $75.37 on Thursday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...